14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 06, 2024 Buy 466 554 Banks Jerel A. Options (right to buy)
Mar 06, 2024 Buy 200 004 Boston Megan Options (right to buy)
Dec 06, 2023 Buy 35 000 Smith Edward F Options (right to buy)
Dec 06, 2023 Buy 35 000 Francis Peter Options (right to buy)
Dec 06, 2023 Buy 35 000 Buchi J Kevin Options (right to buy)
Aug 11, 2023 Buy 25 907 Boston Megan Common Stock
Aug 11, 2023 Buy 25 907 Boston Megan Common Warrants (right to buy)
Aug 11, 2023 Buy 51 813 Buchi J Kevin Common Stock
Aug 11, 2023 Buy 51 813 Buchi J Kevin Common Warrants (right to buy)
Jun 13, 2023 Buy 153 000 Boston Megan Options (right to buy)
Jun 13, 2023 Buy 356 900 Banks Jerel A. Options (right to buy)
Dec 07, 2022 Buy 12 000 Smith Edward F Options (right to buy)
Dec 07, 2022 Buy 12 000 Buchi J Kevin Options (right to buy)
Dec 07, 2022 Buy 12 000 Francis Peter Options (right to buy)
Dec 09, 2021 Buy 10 553 Oliveira Steven Michael Common Stock, par value $0,0001 per share
Dec 08, 2021 Buy 12 000 Buchi J Kevin Options (right to buy)
Dec 08, 2021 Buy 12 000 Smith Edward F Options (right to buy)
Dec 08, 2021 Buy 12 000 Francis Peter Options (right to buy)
Nov 29, 2021 Buy 37 947 Oliveira Steven Michael Common Stock, par value $0,0001 per share
May 03, 2021 Buy 40 500 Oliveira Steven Michael Common Stock, par value $0,0001 per share
Apr 30, 2021 Buy 120 000 Oliveira Steven Michael Common Stock, par value $0,0001 per share
Apr 29, 2021 Buy 22 877 Oliveira Steven Michael Common Stock, par value $0,0001 per share
Apr 28, 2021 Buy 100 000 Oliveira Steven Michael Common Stock, par value $0,0001 per share
Apr 12, 2021 Buy 0 Oliveira Steven Michael Common Stock, par value $0.0001 per share
Dec 09, 2020 Buy 23 601 Buchi J Kevin Options (right to buy)
Dec 09, 2020 Buy 23 601 Francis Peter Options (right to buy)
Dec 09, 2020 Buy 23 601 Francis Peter Options (right to buy)
Dec 09, 2020 Buy 23 601 Smith Edward F Options (right to buy)
Dec 09, 2020 Buy 142 172 Boston Megan Options (right to buy)
Dec 09, 2020 Buy 284 345 Banks Jerel A. Options (right to buy)
Apr 15, 2020 Buy 0 Nant Capital, Llc Common Stock
Apr 15, 2020 Buy 0 Nant Capital, Llc Common Stock
Apr 15, 2020 Buy 33 333 Banks Jerel A. Options (right to buy)
Apr 15, 2020 Buy 0 Francis Peter Common Stock
Apr 15, 2020 Buy 0 Francis Peter Common Stock
Apr 15, 2020 Buy 4 666 Francis Peter Options (Right to Buy)
Apr 15, 2020 Buy 0 Smith Edward F No securities are beneficially owned
Apr 15, 2020 Buy 0 Buchi J Kevin Common Stock
Apr 15, 2020 Buy 2 800 Buchi J Kevin Options (Right to Buy)
Apr 15, 2020 Buy 0 Boston Megan Common Stock
Apr 15, 2020 Buy 16 666 Boston Megan Options (Right to Buy)
INSIDER POWER
94.418
Last 41 transactions
Buy: 2 419 161 | Sell: 0 (Shares)

Based on the 41 latest insides trades, we have calculated the insider power to be positive at a ratio of 94.418.

In total, the insiders bought 2 419 161 and sold 0 BNTC shares in the last 41 trades.

Click to get the best stock tips daily for free!

About Benitec Biopharma Limited

Benitec Biopharma Limited Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company w... BNTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT